发明名称 |
Composition and dosage form for sustained effect of levodopa |
摘要 |
The present invention encompasses compositions for the treatment of Parkinson's disease comprising a therapeutically effective amount of levodopa or a metabolic precursor thereof and at least one dopamine transport inhibitor in sufficient amount to decrease dopamine degradation, wherein the dopamine transport inhibitor is administered to avoid dyskinesia.
|
申请公布号 |
US2005113452(A1) |
申请公布日期 |
2005.05.26 |
申请号 |
US20040966090 |
申请日期 |
2004.10.14 |
申请人 |
FLASHNER-BARAK MOSHE;LERNER E. I.;ROSENBERGER VERED |
发明人 |
FLASHNER-BARAK MOSHE;LERNER E. I.;ROSENBERGER VERED |
分类号 |
A61K31/135;A61K31/137;A61K31/198;A61K31/445;A61K31/4458;(IPC1-7):A61K31/445 |
主分类号 |
A61K31/135 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|